Literature DB >> 11058121

Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.

H Yoo1, R L Juliano.   

Abstract

PAMAM dendrimers are cationic polymers that have been used for the delivery of genes and oligonucleotides to cells. However, little is known about the behavior of dendrimer-nucleic acid complexes once they reach the cell interior. To pursue this issue, we prepared dendrimers conjugated with the fluorescent dye Oregon green 488. These were used in conjunction with oligonucleotides labeled with a red (TAMRA) fluorophore in order to visualize the sub-cellular distribution of the dendrimer-oligonucleotide complex and of its components by two-color digital fluorescence microscopy. The 2'-O:-methyl antisense oligonucleotide sequence used in these studies was designed to correct splicing at an aberrant intron inserted into a luciferase reporter gene; thus effective delivery of the antisense agent results in the expression of the reporter gene product. The dendrimer-oligonucleotide complex remained associated during the process of uptake into vesicular compartments and eventual entry into the nucleus. Since the pharmacological activity of the antisense compound was manifest under these conditions, it suggests that the dendrimer-oligonucleotide complex is functionally active. A surprising result of these studies was that the Oregon green 488-conjugated dendrimer was a much better delivery agent for antisense compounds than unmodified dendrimer. This suggests that coupling of relatively hydrophobic small molecules to PAMAM dendrimers may provide a useful means of enhancing their capabilities as delivery agents for nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058121      PMCID: PMC113155          DOI: 10.1093/nar/28.21.4225

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

Review 1.  Cationic liposome-mediated gene transfer.

Authors:  X Gao; L Huang
Journal:  Gene Ther       Date:  1995-12       Impact factor: 5.250

2.  Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery.

Authors:  R Delong; K Stephenson; T Loftus; M Fisher; S Alahari; A Nolting; R L Juliano
Journal:  J Pharm Sci       Date:  1997-06       Impact factor: 3.534

Review 3.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

4.  Mechanism of oligonucleotide release from cationic liposomes.

Authors:  O Zelphati; F C Szoka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  DNA complexing with polyamidoamine dendrimers: implications for transfection.

Authors:  A U Bielinska; C Chen; J Johnson; J R Baker
Journal:  Bioconjug Chem       Date:  1999 Sep-Oct       Impact factor: 4.774

6.  Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.

Authors:  O Zelphati; F C Szoka
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

7.  Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules.

Authors:  S B Rajur; C M Roth; J R Morgan; M L Yarmush
Journal:  Bioconjug Chem       Date:  1997 Nov-Dec       Impact factor: 4.774

8.  Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.

Authors:  S K Alahari; N M Dean; M H Fisher; R Delong; M Manoharan; K L Tivel; R L Juliano
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

9.  Oligonucleotide dendrimers: synthesis and use as polylabelled DNA probes.

Authors:  M S Shchepinov; I A Udalova; A J Bridgman; E M Southern
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

10.  Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.

Authors:  Q Zhao; J Temsamani; S Agrawal
Journal:  Antisense Res Dev       Date:  1995
View more
  32 in total

Review 1.  Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.

Authors:  Jonathan R Slotkin; Kevin S Cahill; Suzanne A Tharin; Erik M Shapiro
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Developmental toxicity of low generation PAMAM dendrimers in zebrafish.

Authors:  Tisha C King Heiden; Emelyne Dengler; Weiyuan John Kao; Warren Heideman; Richard E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  2007-07-31       Impact factor: 4.219

3.  Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin.

Authors:  D Shcharbin; B Klajnert; V Mazhul; M Bryszewska
Journal:  J Fluoresc       Date:  2005-01       Impact factor: 2.217

4.  PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.

Authors:  Quan Yuan; W Andrew Yeudall; Hu Yang
Journal:  Biomacromolecules       Date:  2010-08-09       Impact factor: 6.988

Review 5.  Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Authors:  Hu Yang
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

6.  Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.

Authors:  Hyunmin Kang; Robert DeLong; Michael H Fisher; Rudolph L Juliano
Journal:  Pharm Res       Date:  2005-10-01       Impact factor: 4.200

7.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

8.  Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.

Authors:  J Oliver McIntyre; Barbara Fingleton; K Sam Wells; David W Piston; Conor C Lynch; Shiva Gautam; Lynn M Matrisian
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro.

Authors:  Shan-zhi Gu; Xin-han Zhao; Ling-xiao Zhang; Li Li; Zhi-yu Wang; Min Meng; Gai-li An
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

10.  Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives.

Authors:  V Gajbhiye; P Vijayaraj Kumar; A Sharma; A Agarwal; A Asthana; N K Jain
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.